筛选
科学数据
统计数据
共检索到36条 ,权限内显示50条;
Engaging northern communities in the monitoring of country food safety and wildlife health
- 负责人:
- Canadian Polar Data Network (CPDN)
- 关键词:
- Anisakidae E. coli Fishes Mammals Pathogen Salmonella Toxoplasma gondii Traditional food Trichinella Zoonosis
- DOI:
- doi:10.5443/11448
- 摘要:
- d to detect Toxoplasma DNA in meat, and antibodies in blood or tissue fluid, respectively, 9) an absorbent filter paper method to collect blood under Arcti
and synthesis of proinflammatory cytokines by such cells, via inhibition of NF-?B
- 负责人:
- 关键词:
- DOI:
- doi:10.5061/dryad.704q3
- 摘要:
- Introduction: Oxidative stress plays a role in the pathogenesis of rheumatoid arthritis (RA). Anthocyanin is a plant antioxidant. We investi
Experimental results of a Lateral Flow Immunochromatographic Strip Test method for rapid detection of Oseltamivir Phosphate in egg and chicken meat
- 负责人:
- 关键词:
- 30104 Immunological and Bioassay Methods Immunology 119999 Medical and Health Sciences not elsewhere classified
- DOI:
- doi:10.6084/m9.figshare.7306373.v1
- 摘要:
- to High Performance Liquid Chromatography (HPLC) and Liquid Chromatography Mass Spetography (LC-MS), in detection of OP residues in poultry products. OP is an ethyl ester prodrug used to treat
Governance of Livestock Disease, 2007-2010;;GoLD; Decision-Making Frameworks in Management of Livestock Disease
- 负责人:
- 关键词:
- DOI:
- doi:10.5255/ukda-sn-7011-1
- 摘要:
- e subsequently analysed for antibodies to five endemic diseases in the Biotechnology and Biological Sciences Research Council (BBSRC) project BBS/B/04854 <
Data from: Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study
- 负责人:
- DOI:
- doi:10.5061/dryad.t8s1227
- 摘要:
- Objective: To evaluate the efficacy and safety of galcanezumab, a humanized monoclonal antibody that selectively binds
Data from: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
- 负责人:
- 关键词:
- influenza;cochrane;neuraminidase inhibitor;clinical study reports;relenza;zanamivir;oseltamivir
- DOI:
- doi:10.5061/dryad.77471
- 摘要:
- on of children on oseltamivir with a four-fold increase in antibodies (RR 0.90, 95% CI 0.80 to 1.00, I2 = 0%). Prophylaxis. In prophylaxis trials, oseltamivir